Abstract
Excessive gut luminal iron contributes to the initiation and progression of colorectal cancer. However, emerging evidence suggests that reduced iron intake and low systemic iron levels are also associated with the pathogenesis of colorectal cancer. This is important because patients with colorectal cancer often present with iron deficiency. Iron is necessary for appropriate immunological functions; hence, iron deficiency may hinder cancer immunosurveillance and potentially modify the tumor immune microenvironment, both of which may assist cancer development. This is supported by studies showing that patients with colorectal cancer with iron deficiency have inferior outcomes and reduced response to therapy. Here, we provide an overview of the immunological consequences of iron deficiency and suggest ensuring adequate iron therapy to limit these outcomes.Citation
Phipps, O., Brookes, M.J. and Al-Hassi, H.O. (2021) Iron deficiency, immunology and colorectal cancer, Nutrition Reviews, 79(1), pp. 88–97.Publisher
Oxford University PressJournal
Nutrition ReviewsAdditional Links
https://academic.oup.com/nutritionreviewsType
Journal articleLanguage
enDescription
This is an accepted manuscript of an article published by OUP in Nutrition Reviews on 17/7/2020, available online at: https://doi.org/10.1093/nutrit/nuaa040 The accepted version of the publication may differ from the final published version.ISSN
0029-6643EISSN
1753-4887ae974a485f413a2113503eed53cd6c53
10.1093/nutrit/nuaa040
Scopus Count
Collections
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/